Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke

Phase 1

Completed

Conditions: Stroke

Interventions: Device: Telerehabilitation
Drug: Placebo
Drug: Sinemet Pill

First Posted Date: 2022-05-11

Last Posted Date: 2025-03-24

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 25

Registration Number: NCT05369533

Locations: 🇺🇸
California Rehabilitation Institute, Los Angeles, California, United States

Brain Changes in Pediatric OSA

Not Applicable

Completed

Conditions: Pediatric Obstructive Sleep Apnea

Interventions: Procedure: Adenotonsillectomy

First Posted Date: 2022-05-10

Last Posted Date: 2024-11-28

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 56

Registration Number: NCT05368077

Locations: 🇺🇸
UCLA, Los Angeles, California, United States

FAPI PET for Lung Fibrosis

Early Phase 1

Recruiting

Conditions: Radiation Pneumonitis
Interstitial Lung Disease
Idiopathic Interstitial Pneumonias
Drug-Induced Pneumonitis
Pulmonary Fibrosis
Hypersensitivity Pneumonitis
Pneumoconiosis

Interventions: Drug: 68Ga-FAPi-46
Procedure: Computed Tomography
Procedure: Positron Emission Tomography
Procedure: High Resolution Computed Tomography

First Posted Date: 2022-05-09

Last Posted Date: 2024-05-02

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 30

Registration Number: NCT05365802

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Aging and Reward System Response to Inflammation and Anxiety Study

Phase 1

Recruiting

Conditions: Inflammation
Anxiety
Aging
Anhedonia
Depression

Interventions: Biological: Endotoxin
Biological: Placebo

First Posted Date: 2022-05-06

Last Posted Date: 2024-07-25

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 80

Registration Number: NCT05363527

Locations: 🇺🇸
Norman Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, California, United States

Stigma Among Women With HIV in Vietnam

Not Applicable

Completed

Conditions: Stigma, Social
Discrimination, Sex
HIV Infections

Interventions: Behavioral: Suppress Stigma, Support Services

First Posted Date: 2022-05-02

Last Posted Date: 2025-04-02

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 91

Registration Number: NCT05357118

Locations: 🇻🇳
Hanoi Medical University, Hanoi, Vietnam

Transvaginal Electrical Stimulation for Myofascial Pelvic Pain

Not Applicable

Recruiting

Conditions: Myofascial Pelvic Pain

Interventions: Behavioral: Standard care
Device: Urostym

First Posted Date: 2022-05-02

Last Posted Date: 2025-04-23

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 60

Registration Number: NCT05354869

Locations: 🇺🇸
UCLA Center for Women's Pelvic Health, Los Angeles, California, United States

Recording of Intraoperative Spinal Cord Stimulation and Monitoring

Not Applicable

Recruiting

Conditions: Disk, Herniated
Spondylosis
Cervical Stenosis

Interventions: Device: epidural electrical stimulation

First Posted Date: 2022-05-02

Last Posted Date: 2025-03-10

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 150

Registration Number: NCT05356286

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Kind Minds Program for Youth With Anxiety and Depression

Not Applicable

Recruiting

Conditions: Child Anxiety
Depression

Interventions: Behavioral: Kind Minds Program

First Posted Date: 2022-04-29

Last Posted Date: 2025-05-13

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 30

Registration Number: NCT05353751

Locations: 🇺🇸
Imperial High School, Imperial, California, United States

Bereaved Young Adults Study

Not Applicable

Completed

Conditions: Bereavement

Interventions: Behavioral: Expressive Helping
Behavioral: Fact-Writing
Behavioral: Expressive Disclosure

First Posted Date: 2022-04-28

Last Posted Date: 2023-05-16

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 178

Registration Number: NCT05352243

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Metformin Treatment in Progressive Multiple Sclerosis

Early Phase 1

Recruiting

Conditions: Secondary Progressive Multiple Sclerosis
Primary Progressive Multiple Sclerosis

Interventions: Drug: Metformin 500 Mg Oral Tablet, up to 4 tablets a day
Drug: Placebo oral tablet identical to metformin, up to 4 tablets a day

First Posted Date: 2022-04-27

Last Posted Date: 2025-05-01

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 44

Registration Number: NCT05349474

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy